Infectious Diseases
Findings from University of Miami Advance Knowledge in Infectious Diseases
Published in TB and Outbreaks Week, October 18th, 2011
2011 OCT 18 -- According to the authors of recent research published in the Journal of Infectious Diseases, "AIDS Clinical Trials Group A5202 compared blinded abacavir/lamivudine (ABC/3TC) to tenofovir DF/emtricitabine (TDF/FTC) with efavirenz (EFV) or atazanavir/ritonavir (ATV/r) in human immunodeficiency virus (HIV)-infected treatment-naive patients, stratified by screening HIV RNA (< or >= 10(5) copies/mL). Due to higher virologic failure with ABC/3TC in the high HIV RNA stratum, blinded treatment was stopped in this group, but study follow-up continued for all patients."
"Primary endpoints were times to virologic failure, regimen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Meningitis
Findings from University of Bern in Meningitis Reported - Airborne Disease
Reports from University of Milan Add New Data to Research in Airborne Disease - Pandemics
Research Reports on Pandemics from St. Jude Children's Research Hospital Provide New Insights - Pandemics
Researchers' Work from University of Cambridge Focuses on Pandemics - Mycoses
Findings from A. Glockner and Co-Authors Provide New Insights into Mycoses - Influenza A Virus Subtype H5N1
Initial immunization with DNA vaccine boosts effectiveness of traditional influenza vaccine and could help prepare for future pandemics - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
